Abstract
Background
Aberrant activation of macrophages is associated with pathogenesis of acute lung injury (ALI). However, the potential pathogenesis has not been explored.
Objectives
We aimed to identify whether histone deacetylase (HDAC) 10 is involved in lipopolysaccharide (LPS)-exposed ALI and reveal the underlying pathogenesis by which it promotes lung inflammation in LPS-exposed ALI via modifying P62 with deacetylation.
Methods
We constructed an ALI mice model stimulated with LPS to determine the positive effect of Hdac10 deficiency. Moreover, we cultured murine alveolar macrophage cell line (MH-S cells) and primary bone marrow-derived macrophages (BMDMs) to explore the pro-inflammatory activity and mechanism of HDAC10 after LPS challenge.
Results
HDAC10 expression was increased both in mice lung tissues and macrophage cell lines and promoted inflammatory cytokines production exposed to LPS. Hdac10 deficiency inhibited autophagy and inflammatory response after LPS stimulation. In vivo, Hdac10fl/fl-LysMCre mice considerably attenuated lung inflammation and inflammatory cytokines release exposed to LPS. Mechanistically, HDAC10 interacts with P62 and mediates P62 deacetylation at lysine 165 (K165), by which it promotes P62 expression and increases inflammatory cytokines production. Importantly, we identified that Salvianolic acid B (SAB), an HDAC10 inhibitor, reduces lung inflammatory response in LPS-stimulated ALI.
Conclusion
These results uncover a previously unknown role for HDAC10 in regulating P62 deacetylation and aggravating lung inflammation in LPS-induced ALI, implicating that targeting HDAC10 is an effective therapy for LPS-exposed ALI.
Similar content being viewed by others
Introduction
Acute lung injury (ALI) is a clinical syndrome caused by a variety of direct or indirect factors [1]. Since the Berlin definition in 2012, ALI is commonly used to describe the general condition or animal models that fail to meet the clinical definition criteria [2]. Meanwhile, the potential mechanisms of ALI are not well understood, there is not yet an effective specific targeted therapy for ALI. Hence, there is an urgent need to investigate the pathogenesis and potential mechanisms underlying ALI.
Lung macrophages are essential for the inflammatory response in ALI. Under physiologic condition, alveolar macrophages (AMs) are involved in a variety of immune diseases and maintain airway homeostasis [3]. During the inflammatory period of ALI, AMs can produce various inflammatory cytokines [4]. It has been reported that adipose-derived mesenchymal stem cell-derived exosomes (AdMSC-Exos) can improve the integrity of mitochondrial components to promote macrophage homeostasis and alleviate inflammation in ALI [5]. Cluster of differentiation 36 (CD36) deficiency attenuates M1 polarization of macrophages and thus alleviates ALI [6]. Nevertheless, the role of autophagy in macrophages during LPS-stimulated ALI remains largely unexplored.
Acetylation, as a well-explored post-translational modification (PTM), intricately regulates various cellular physiological processes. Histone deacetylases (HDACs), crucial enzymes in this process, catalyze the removal of acetyl groups from histone lysines [7]. In recent studies, HDACs have been played an important role in ALI: HDAC5 deacetylates Lys136 of PP2Ac, inhibits its phosphatase activity, and negatively regulates the LPS-challenged ALI lung inflammation [8]. HDAC6 promotes the secretion of inflammatory cytokines in macrophages, activates the AP-1 and NF-κB pathways, and ultimately leads to ALI [9]. HDAC10 participated in temporomandibular arthritis, and HDAC10 overexpression activates the NF-κB pathway and aggravates inflammation response [10]. However, the mechanism of how HDAC10 regulates macrophage activation in ALI is still unclear.
Autophagy is a cellular mechanism that facilitates self-renewal and preservation by degrading proteins or its own organelles. Autophagy has gained significant attention due to its role in various diseases [11], including its significant role in ALI [12]. P62, a multidomain, multifunctional protein with 440 amino acids, involving in inflammation, cell homeostasis regulation, and cancer via various mechanisms by binding to various proteins [13]. Sitagliptin facilitates the activation of the p62-Keap1-Nrf2 pathway, thereby mitigating oxidative stress and hyperautophagy in ALI associated with severe acute pancreatitis [14]. Dapk1 suppresses autophagy and mitigates oxidative stress in LPS-treated ALI via inhibiting the p38MAPK/NF-κB signaling pathway [15]. These findings underscore the pivotal role of P62 in the inflammatory response characteristic of ALI. However, the underlying mechanisms by which it is involved remain unreported.
In our study, we observed an increase of HDAC10 expression in macrophages. Furthermore, our findings demonstrate that deficiency of HDAC10 confers protection against LPS-induced ALI. Mechanistically, HDAC10 interacts with P62, and HDAC10 acts as a regulator of P62Lys165 to promote lung inflammation of LPS-treated ALI.
Results
HDAC10 expression is increased in the lung macrophages following LPS exposure
To determine whether HDAC10 is involved in LPS-treated ALI, we initially detected HDAC10 expression in ALI mice lung tissues. Our findings revealed an obvious increase of HDAC10 mRNA levels in LPS-exposed ALI mice lung tissues compared to those of normal controls (Fig. 1A). These results were revealed by Western Blotting (WB) and immunohistochemistry (IHC) (Fig. 1B-E). Moreover, the immunofluorescent staining result showed that HDAC10 was co-localized with macrophage marker F4/80 (Fig. 1F, G). In addition, we detected HDAC10 expression in the MH-S cells exposed to LPS by WB, qRT-PCR (Fig. 1H-K) and immunofluorescence (IF) (Figure S1A, B). Then, we subjected BMDMs to similar LPS stimulation conditions as MH-S cells and observed HDAC10 expression was increased after LPS stimulation (Figure S1C-F). Collectively, these results indicated that HDAC10 was obviously expressed after treated with LPS in macrophages, which encouraged us to further investigate its role in LPS-induced ALI.
Hdac10 deficiency attenuates LPS-induced lung inflammation in ALI
To explore how HDAC10 regulates lung inflammation of ALI, we constructed Hdac10-deficient (mainly in macrophages) mice using genetic engineering (Fig. 2A). The mice representative genotyping results as shown in Fig. 2B. Then, Fig. S2A, B results showed that HDAC10 gene was successfully knocked out. The Hdac10fl/fl-LysMCre and Hdac10fl/fl mice were stimulated with LPS according to the following method. The total cells of mice bronchoalveolar lavage fluid (BALF) in Hdac10fl/fl-LysMCre mice were dramatically lower than those in Hdac10fl/fl mice treated with LPS (Fig. 2C, D). Hematoxylin & eosin (HE) staining was decreased in LPS-induced Hdac10fl/fl-LysMCre mice (Fig. 2E, F).
The secretion of inflammatory cytokine in Hdac10fl/fl-LysMCre mice lung tissues exhibited a significant reduction compared to that observed in Hdac10fl/fl mice treated with LPS (Fig. 2G-J). Then, we also detected the protein levels of CXCL1 and CXCL2, the results showed by ELISA (Fig. 2K, M). We further cultured BMDMs isolated from Hdac10fl/fl and Hdac10fl/fl-LysMCre mice, which were exposed to LPS for 3 h, and found that Hdac10 knockout reduced inflammatory cytokine production (Fig. S2C-F). Collectively, these datas suggested that Hdac10 deficiency in macrophages was sufficient to repress LPS-exposed lung inflammation.
Hdac10 deficiency suppresses autophagy to inhibit inflammatory cytokine production
Autophagy plays a key role in ALI. P62, a selective receptor of autophagy, regulates cell survival, inflammation and participates in a number of diseases [13]. However, it is unknown whether P62 participates in LPS-induced ALI and whether HDAC10 regulates P62 in macrophages. To confirm this question, we first assessed the expressions of LC3B and P62. We discovered that LC3B and P62 expressions were increased in lung tissues of ALI mice and LPS-treated MH-S cells (Fig. 3A, B), whereas the expressions of LC3B and P62 in the lung tissue of Hdac10fl/fl-LysMCre ALI mice were lower than those of Hdac10fl/fl ALI mice (Fig. 3C, D). Consistently, the expressions of LC3B and P62 were reduced in Hdac10fl/fl-LysMCre BMDMs compared with Hdac10fl/fl BMDMs after LPS challenge (Fig. 3E). Moreover, the inhibition of autophagy in Hdac10fl/fl-LysMCre BMDMs exposed to LPS was assessed by transmission electron microscopy (TEM) and Monodansylcadaverine (MDC) staining (Fig. 3F, G). Then, we found that autophagy inhibitor-chloroquine (CQ) treatment reduced inflammatory cytokines production in MH-S cells after exposure to LPS (Fig. 3H-K). In conclusion, inhibition of autophagy alleviated the inflammation of ALI. Therefore, our findings discovered that HDAC10 regulates the inflammatory response of LPS-exposed ALI by affecting autophagy, and Hdac10 deficiency suppresses autophagy to inhibit inflammatory cytokine production.
HDAC10 directly binds with P62 and targets P62 for deacetylation
To explore the mechanisms of HDAC10 regulating P62 during ALI, we have done some experiments. Coimmunostaining confirmed the expression and colocalized of HDAC10 and P62 in MH-S cells (Fig. 4A), while co-immunoprecipitation (Co-IP) determined interaction between HDAC10 and P62. These results demonstrate the coimmunoprecipitation of HDAC10 and P62, indicating their potential interaction in cellular processes (Fig. 4B-E).
We have confirmed that HDAC10 interacts with P62, and HDAC10 is a deacetylase that potentially mediates the deacetylation of P62. We found that the acetylation level of P62 was decreased after HDAC10 overexpression in HEK 293T cells (Fig. 4F). Then, we overexpressed P62 in HEK 293T cells, which was stimulated by the histone deacetylase inhibitor trichostatin A (TSA). We found that P62 acetylation was increased with the extension of TSA stimulation time (0 h~4 h) (Fig. 4G). To determine potential acetylated lysine site of P62, Acetylated lysine (K) sites of P62 were further predicted using CSS-Palm 3.0. and three acetylated lysine sites (K13, K165 and K435) were performed (Fig. 4H). Then, we constructed acetylation defective P62 mutants with each lysine residue replaced by arginine (K13R, K165R, and K435R) and detected their deacetylation. Notably, the K165R mutant, but not K13R or K435R mutants, exhibited reduced acetylation levels (Fig. 4I). K165 after simulated acetylation (Q) and deacetylation (R), their acetylation levels were detected by IP, the acetylation levels of WT-P62 were increased, and the acetylation levels of K165R and K165Q were decreased (Fig. 4J). In addition, we co-overexpressed Flag-HDAC10, HA-P62 (WT), HA-K165R, and HA-K165Q in HEK 293T cells, and evaluated the interaction between HDAC10 and P62, K165R, and K165Q via Co-IP. The results indicated a decreased interaction between HDAC10 and K165R compared to that between HDAC10 and P62 and K165Q (Fig. 4K).
HDAC10 deacetylates P62-K165 to regulate inflammation in LPS-exposed ALI
We have confirmed that K165 was the major acetylation site of P62. Acetylation-defective substitution at K165 (K165R) significantly increased LPS-induced inflammatory cytokines production in Hdac10fl/fl BMDMs, but K165Q (the lysine mutation to glutamine) had no such effect (Fig. 5A-E). Consistent with these findings, co-overexpression of HDAC10 and K165 prompted inflammatory cytokines secretion in Hdac10fl/fl BMDMs (Fig. 5F-J). Furthermore, we investigated whether the elevation of P62-K165R could reverse the marked reduction in cytokine levels observed in Hdac10-deficient macrophages. The results showed that an increase in P62-K165R indeed counteracted the substantial decline in cytokine levels observed in Hdac10fl/fl-LysMCre BMDMs (Fig. S3A-E). Taken together, our datas suggested that HDAC10 regulates inflammation in LPS-induced ALI via deacetylating P62 at K165.
HDAC10 inhibitor treatment attenuates LPS-induced lung inflammation in ALI
Our findings discovered that targeting HDAC10 in LPS-induced ALI may be a potential treatment. We then evaluated the role of HDAC10 inhibitor Salvianolic acid B (SAB) in experimental mouse models. We observed a reduction in total cells of BALF in LPS-treated ALI mice following exposure to SAB (Fig. 6A, B). Additionally, HE staining revealed that SAB treatment mitigated lung inflammation in LPS-exposed mice (Fig. 6C, D). In addition, P62 protein level in LPS+SAB-treated mice was lower than LPS-exposed mice (Fig. 6E). To explore the effect of SAB on protein acetylation levels, we overexpressed P62 and K165R in HEK 293T cells and found that SAB increased the acetylation of both the whole protein and K165R (Fig. 6F). Moreover, the secretion of inflammatory cytokines in LPS+SAB-treated mice was decreased compared to those in LPS-exposed mice (Fig. 6G-J). We have also detected the protein levels of CXCL1 and CXCL2 by ELISA (Fig. 6K, M). Consistent with the in vivo findings, LPS-exposed MH-S cells exhibited elevated expression of P62 and inflammatory cytokines, which was reduced by SAB treatment (Figure S4A-E). To sum up, our findings hinted that the HDAC10 inhibitor SAB may play a significant role in reducing lung inflammation of LPS-treated ALI.
Discussion
Our study suggested that HDAC10 was elevated in LPS-treated ALI mice and in vitro following LPS exposure. Mice with a macrophage-specific deletion of Hdac10 alleviated lung inflammation in LPS-stimulated ALI. HDAC10 interacted with P62 and deacetylated P62 at lysine 165, by which facilitated the LPS-exposed ALI pulmonary inflammation. In additional, we found that SAB reduced the inflammatory response in LPS-stimulated ALI mice. Overall, our study discovered that HDAC10 played a crucial role in regulating lung inflammation by deacetylating P62Lys165, thus promoting lung inflammation in LPS-exposed ALI (Figure S5). ALI has a high morbidity and mortality in clinical practice [16], causing a huge economic burden to the society, if not treated in time, the patient will eventually die due to respiratory failure. Therefore, it is imperative to develop new strategies to target the molecular mechanisms of ALI. In our study, HDAC10 clearly exists as an adverse influence factor of ALI and determines the mechanism by which HDAC10 aggravates the lung inflammation of ALI.
As a key mechanism of epigenetics, histone modification involves alterations to chromatin structure through modifications of histones, thereby influencing gene expression. Consequently, HDACs are implicated in the pathogenesis of many diseases, such as inflammatory conditions, cancer, and immune disease [17]. HDAC10 stands out as a novel histone deacetylase, it deacetylates histones and inhibits transcription, and it plays a critical role in cell cycle development, hormone regulation, lipid metabolism and autophagy regulation [18]. It has been reported that HDAC10 deficiency enhances Foxp3+ T-regulatory cell function, and the HDAC10-specific inhibitors hold promise for treating immune-related disorders [19]. In addition, HDAC10 negatively regulates lung cancer development by promoting protein kinase B (AKT) phosphorylation [20]. These studies had shown that HDAC10 was particularly important in cell and lung development. However, there is no study to explore the role of HDAC10 in LPS-treated ALI. Here, we found that HDAC10 is significantly increased in mice lung tissues and cell lines exposed to LPS. Hdac10 deficiency attenuates LPS-induced lung inflammation in ALI. In addition, we found SAB as a HDAC10 inhibitor that prevented lung injury and inflammation after LPS stimulation.
In recent years, more and more studies have shown that autophagy clears invading pathogens and involves in ALI/ARDS. Besides, the regulatory influence of acetylation on autophagy has attracted increasing attention. For instance, General Control Non-Repressed Protein 5 (GCN5) has been shown to acetylate transcription factor EB (TFEB), thereby reducing TFEB's transcriptional activation and subsequently decreasing lysosome formation during autophagy [21]. Furthermore, HDAC10 has been observed to interact with Microtubule-Associated Protein Light Chain 3 (LC3), an interaction inhibited by the autophagy inhibitor chloroquine. This inhibition promotes the phosphorylation of interferon regulatory factor 3 (IRF3), thereby enhancing IRF3-mediated antiviral immune responses [22]. Selective autophagy mediated by P62 has been implicated in the inflammation observed in sepsis, with autophagy deficiency being a significant contributing factor to sepsis development. It is worth noting that sepsis is one of the causes of ALI/ARDS. Li et al. found that Heme oxygenase-1 (HO-1) mitigated the inflammatory response in sepsis-induced ALI by activating the autophagy flux axis and inhibiting the NLRP3 inflammasome [23]. Although P62-mediated autophagy is implicated in ALI, its exact molecular mechanism remains unclear. Here, Hdac10 deficiency significantly attenuated P62 expression in BMDMs following LPS exposure. We found that HDAC10 interacted with P62 and mediates P62 deacetylation at lysine 165. However, the underlying mechanisms of P62 deacetylation that regulates macrophage autophagy requires further investigation.
In summary, our experiments demonstrated that HDAC10 interacts with P62 and mediates P62 deacetylation at lysine 165 (K165), by which it promotes P62 expression and increases LPS-induced lung inflammation and may suggest that inhibition of HDAC10 could prevent the development of ALI-induced lung inflammation.
Materials and methods
Animal experiment
The LysMCre mice obtained from Dr. G. Feng (University of California, San Diego, USA). Hdac10fl/fl mice were generated by Cyagen Biosciences Inc. (Suzhou, China) using the CRISPR-Cas9 system. To generate Hdac10fl/fl-LysMCre mice, the LysMCre mice were crossed with Hdac10fl/fl mice to obtain it. The study protocol was approved by the Animal Ethics Committee of Guangdong Medical University.
Acute lung injury mouse model
Hdac10fl/fl and Hdac10fl/fl-LysMCre mice were used to construct acute lung injury (ALI) model, which were divided into Hdac10fl/fl and Hdac10fl/fl-LysMCre control group, Hdac10fl/fl and Hdac10fl/fl-LysMCre ALI group. To induce the ALI model, the mice were intratracheal instillated with 100 μg LPS in 50 μl normal saline. The HDAC10 inhibitor (salvianolic acid B) was intraperitoneally given to the mice 1 h before the LPS treatment. After 24 h of LPS stimulation, the mice were sacrificed by intraperitoneal injection of pentobarbital sodium (250 mg/kg).
Histological and immunohistochemical analysis
Hematoxylin and eosin (HE) staining was performed to evaluate lung inflammation in ALI mice. Immunostaining staining was displayed co-location of HDAC10 and F4/80 in the mice lung tissues. Immunoconfocal imaging was performed on the sections.
Quantitative RT-PCR (qRT-PCR)
Mice lung tissues and cell total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA, USA). Reverse transcription into cDNA using PrimeScript™RT kit (Takara, Beijing, China). The primer sequences were displayed in Table 1.
Culture and treatment of BMDMs
BMDMs were isolated from C57BL/6J mice and were incubated in DMEM containing 10 ng/ml M-CSF (Novoprotein, Catalog #0331488), 10%FBS and 1% penicillin/streptomycin. BMDMs were exposed to LPS for 2h, 3h or 12h.
Western blotting (WB)
Total proteins were lysed in RIPA buffer. After lysates were electrophoresed and blotted onto polyvinylidene fluoride membrane, which were finally incubated with the corresponding antibodies.
ELISA
The concentrations of CXCL1 and CXCL2 in the mice lung tissues were measured using ELISA kits (eBioscience, Inc) following the instructions.
Immunofluorescence (IF)
After cell samples fixed with 4% paraformaldehyde, they were incubated with the antibody against HDAC10 (1:150, Affinity, #AF5474) and P62 (1:150, Abcam, ab56416) overnight at 4 °C. Finally, cell samples were assessed by confocal microscopy (Olympus FV3000; Japan).
Co-immunoprecipitation (Co-IP)
Protein samples were quantified using the BCA kit (Beyotime) and divided into input and IP groups. The IP group was incubated with 1 μg antibodies and 50 μl Protein G Beads overnight at 4 °C, while the input group was treated with 5×SDS Sample Buffer and boiled. After washing with IP lysis buffer (containing 1% PMSF), the IP group was boiled again with 2×SDS Sample Buffer.
Transmission electron microscopy
BMDMs were cultured in 24-well plates containing cell culture plates and differentiated into macrophages stimulated with M-CSF. After stimulation with LPS for 3 hours, BMDMs were fixed in 2.5% glutaraldehyde, dehydrated, and embedded in epoxy resin. Samples were meticulously sectioned into ultrathin slices measuring 60-80 nm in thickness. Finally, autophagosomes were captured under transmission electron microscopy.
Monodansylcadaverine (MDC) staining
Following stimulation with LPS for 3 hours, BMDMs were stained with MDC (50 µmol/L) for 30 min. Subsequently, BMDMs were washed with 1ml Assay Buffer for 3 times. Finally, the autophagy of cells was photoed by fluorescence microscope.
Reagents and antibodies
Please see the Table 2.
Ethical approval
All animal experiments were approved by the Animal Ethics Committee of Guangdong Medical University.
Statistical analysis
Results were represented as mean ±SEM. All datas were analyzed by GraphPad Prism 8.0 (San Diego, CA). Unpaired t-tests were used to compare differences between two experimental groups. One-Way ANOVA followed by Tukey's multiple comparisons test was used for multiple group comparisons. p < 0.05 was considered meaningful.
Availability of data and materials
No datasets were generated or analysed during the current study.
Abbreviations
- HDAC10:
-
Histone deacetylase 10
- BMDMs:
-
Primary bone marrow-derived macrophages
- SAB:
-
Salvianolic acid B
- LPS:
-
Lipopolysaccharide
References
Matuschak GM, Lechner AJ. Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment. Mo Med. 2010;107(4):252–58.
Mokra D. Acute lung injury - from pathophysiology to treatment. Physiol Res. 2020;69(Suppl 3):S353–66.
Cheng P, Li S, Chen H. Macrophages in Lung Injury, Repair, and Fibrosis. Cells. 2021;10(2):436.
Chen X, Tang J, Shuai W, Meng J, Feng J, Han Z. Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome. Inflamm Res. 2020;69(9):883–95.
Xia L, Zhang C, Lv N, Liang Z, Ma T, Cheng H, et al. AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages. Theranostics. 2022;12(6):2928–47.
Sun S, Yao Y, Huang C, Xu H, Zhao Y, Wang Y, et al. CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization. Cell Immunol. 2022;372:104475.
Shvedunova M, Akhtar A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol. 2022;23(5):329–49.
Xu C, Tang J, Yang Q, Zhao H, Liu Y, Cao J, et al. Histone deacetylase 5 deacetylates the phosphatase PP2A for positively regulating NF-kappaB signaling. J Biol Chem. 2021;297(6):101380.
Youn GS, Lee KW, Choi SY, Park J. Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-κB/AP-1 signaling pathways in macrophages. Free Radic Biol Med. 2016;97:14–23.
Liao W, Sun J, Liu W, Li W, Jia J, Ou F, et al. HDAC10 upregulation contributes to interleukin 1β-mediated inflammatory activation of synovium-derived mesenchymal stem cells in temporomandibular joint. J Cell Physiol. 2019;234(8):12646–62.
Wang K, Chen Y, Zhang P, Lin P, Xie N, Wu M. Protective Features of Autophagy in Pulmonary Infection and Inflammatory Diseases. Cells. 2019;8(2):123.
Liao SX, Sun PP, Gu YH, Rao XM, Zhang LY, Ou-Yang Y. Autophagy and pulmonary disease. Ther Adv Respir Dis. 2019;13:1753466619890538.
Hennig P, Fenini G, Di Filippo M, Karakaya T, Beer HD. The Pathways Underlying the Multiple Roles of p62 in Inflammation and Cancer. Biomedicines. 2021;9(7):707.
Kong L, Deng J, Zhou X, Cai B, Zhang B, Chen X, et al. Sitagliptin activates the p62-Keap1-Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury. Cell Death Dis. 2021;12(10):928.
Li T, Wu YN, Wang H, Ma JY, Zhai SS, Duan J. Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK/NF-κB signaling pathway. Mol Immunol. 2020;120:13–22.
Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–93.
Hai R, Yang D, Zheng F, Wang W, Han X, Bode AM, et al. The emerging roles of HDACs and their therapeutic implications in cancer. Eur J Pharmacol. 2022;931:175216.
Cheng F, Zheng B, Wang J, Zhao G, Yao Z, Niu Z, et al. Histone deacetylase 10, a potential epigenetic target for therapy. Biosci Rep. 2021;41(6):BSR20210462.
Dahiya S, Beier UH, Wang L, Han R, Jiao J, Akimova T, et al. HDAC10 deletion promotes Foxp3(+) T-regulatory cell function. Sci Rep. 2020;10(1):424.
Yang Y, Huang Y, Wang Z, Wang HT, Duan B, Ye D, et al. HDAC10 promotes lung cancer proliferation via AKT phosphorylation. Oncotarget. 2016;7(37):59388–401.
Wang Y, Huang Y, Liu J, Zhang J, Xu M, You Z, et al. Acetyltransferase GCN5 regulates autophagy and lysosome biogenesis by targeting TFEB. EMBO Rep. 2020;21(1):e48335.
Zhou W, Wang J, Wang X, Wang B, Zhao Z, Fu J, et al. Degradation of HDAC10 by autophagy promotes IRF3-mediated antiviral innate immune responses. Sci Signal. 2022;15(765):eabo4356.
Shutong L, Yu J, Jia W, Huafei D, Shifan Y, Huili W, et al. HO-1/autophagic flux axis alleviated sepsis-induced acute lung injury via inhibiting NLRP3 inflammasome. Cell Signal. 2022;100:110473.
Acknowledgments
This research was supported by National Natural Science Foundation of China (82170030; 82370038), the Guangdong Basic and Applied Basic Research Foundation (2020B1515020004, 2023A1515140172, 2023A1515140082), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Noncommunicable Diseases (2022B1212030003).
Author information
Authors and Affiliations
Contributions
Y.Y.X, Y.Z., X.W.L., and Z.F.F. conducted experiments, data analysis. G.M.S., Y.Y.L., X.T.T., and L.H.O.Y. performed data analysis. X.G., H.Y.Z., and L.L.H,. contributed to data analysis. T.W.L., J.L.C., and J.W.H. analyzed/interpreted results and edited the manuscript. T.W.L. conceived, designed, and supervised the whole study. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
12931_2024_2891_MOESM1_ESM.pdf
Additional file 1: Supplementary Fig. S1. HDAC10 expression is increased in the macrophage cells following LPS exposure. (A, B) Immunofluorescence analysis demonstrating the expression of HDAC10 (green) after 12 h of LPS challenge in MH-S cells. (C, D) HDAC10 protein expression in BMDMs after 100 μg/ml LPS stimulation for 0-12 h and at different concentrations for 12 h. (E, F) HDAC10 mRNA level in BMDMs after 100 μg/ml LPS stimulation for 0-12 h and at different concentrations for 12 h. The data are presented as the mean ±SEM and represent three independent experiments (B, E, F). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
12931_2024_2891_MOESM2_ESM.pdf
Additional file 2: Supplementary Fig. S2. Hdac10-deficient BMDMs inhibit cytokine secretion when exposed to LPS. (A, B) The protein and mRNA levels of HDAC10 in BMDMs from Hdac10fl/fl and Hdac10fl/fl-LysMCre mice. (C-F) The mRNA levels of Cxcl1, Cxcl2, Il-6, and Tnf-α in BMDMs after treated with LPS for 3 h. The data are presents as the mean ± SEM and represent three independent experiments (B-F). *p < 0.05, **p < 0.01, ***p< 0.001.
12931_2024_2891_MOESM3_ESM.pdf
Additional file 3: Supplementary Fig. S3. Hdac10 deficiency acetylates P62-K165 to reduce cytokine secretion. (A) The transiently transfection efficiency of WT-P62 or P62 mutant plasmids (K165R and K165Q) in Hdac10fl/fl-LysMCre BMDMs. (B-E) Hdac10fl/fl-LysMCre BMDMs transiently transfected with WT-P62 or P62 mutant plasmids (K165R and K165Q) for 48h, and then Hdac10fl/fl-LysMCre BMDMs were stimulation with LPS for 3 h. The mRNA levels of Cxcl1, Cxcl2, Il-6 and Tnf-α in Hdac10fl/fl-LysMCre BMDMs detected by qRT-PCR. The data are presents as the mean ± SEM and represent three independent experiments (B-F). *p < 0.05, **p < 0.01, ***p < 0.001.
12931_2024_2891_MOESM4_ESM.pdf
Additional file 4: Supplementary Fig. S4. HDAC10 inhibitor treatment attenuates inflammatory cytokine production in MH-S cells after LPS stimulation. (A) The protein level of P62 in MH-S cells after treated with LPS and SAB. (B-E) The mRNA levels of Cxcl1, Cxcl2, Il-6, and Tnf-α. The data are presents as the mean ± SEM and represent three independent experiments(B-E). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p< 0.0001.
12931_2024_2891_MOESM5_ESM.pdf
Additional file 5: Supplementary Fig. S5. Schematic diagram for Myeloid-specific Hdac10 deletion protects against LPS-induced acute lung injury via P62 acetylation at lysine 165.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Xiang, Y., Zhong, Y., Lai, X. et al. Myeloid-specific Hdac10 deletion protects against LPS-induced acute lung injury via P62 acetylation at lysine 165. Respir Res 25, 263 (2024). https://doi.org/10.1186/s12931-024-02891-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12931-024-02891-2